Status:
UNKNOWN
The Role of Lipofilling After Oncoplastic Breast Surgeries : Evaluation of Outcomes and Patient Satisfaction
Lead Sponsor:
Assiut University
Conditions:
Cancer, Breast
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The Role of Lipofilling After Oncoplastic Breast surgeries : Evaluation of Outcomes and Patient Satisfaction
Detailed Description
Lipofilling is the process of relocating autologous fat to change the shape, volume, consistency and profile of tissues. For over a century, surgeons have used autologous fat to enlarge and reshape th...
Eligibility Criteria
Inclusion
- Female gender.
- Age of 18 years and older.
- History or in candidate for a mastectomy in the near future.
- Patients undergoing prophylactic mastectomy.
- Patients' choice to undergo a breast reconstruction.
- Wanting to participate in this study.
- Patient is able to wear the BRAVA (BRA like VAcuum-based external tissue expander) device.
Exclusion
- Active smoker or a history of smoking 4 weeks prior to surgery.
- Current substance abuse.
- History of lidocaine allergy.
- Four weeks or less after chemotherapy.
- History of radiation therapy in the breast region.
- Oncological treatment includes radiotherapy after mastectomy.
- Kidney disease.
- Steroid dependent (daily or weekly).
- Immune-suppressed or immune-compromised disease.
- Uncontrolled diabetes.
- body mass index of \>30.
- Large breast size (ie, larger than cup C), unless the patient prefers reduction of the contralateral side towards cup C.
- Extracapsular silicone leaking from the encapsulated implant from a previous breast reconstruction.
Key Trial Info
Start Date :
December 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05424666
Start Date
December 19 2022
End Date
September 1 2024
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university
Asyut, Egypt